Category: Biotech & Medtech

  • Biotech & Medtech, Growth-Stage Startups, Industry

Private Capital Reshapes Switzerland’s Biotech Landscape

  • Biotech & Medtech, Industry

Understanding Clinical Trial Phases: A Guide for Swiss Investors

  • Biotech & Medtech, Industry

Biotech vs. Medtech: Understanding the Differences for Your Swiss Portfolio

  • AI & Machine Learning, Biotech & Medtech, Industry

Switzerland Enters a New Era of AI-Driven Medicine

  • Biotech & Medtech, Industry

Understanding Swiss Biotech Valuation: NPV, Risk, and Market Data

  • Biotech & Medtech, Industry

How to Read Clinical Trial Results: A Guide for Swiss Investors

  • Biotech & Medtech, Growth-Stage Startups, Industry

Innosuisse Grants as Validation: What Swiss Government Backing Tells Investors

  • Biotech & Medtech, Industry, Spin-Offs

University Spin-Offs: How ETH, EPFL, and Basel Create Investment Opportunities

  • Biotech & Medtech, Industry

Shifting Patterns in Switzerland’s Patent Landscape

  • Biotech & Medtech, Growth-Stage Startups, HealthTech

How Founder Equity Splits Impact Startup Success: Negotiation Strategies for Swiss Founders

  • Biotech & Medtech, Growth-Stage Startups, HealthTech

Swiss HealthTech and MedTech Startups: Rules for Investing

  • Biotech & Medtech

Biotech & Medtech: Why the Market’s Widening Field Favors Swiss Precision

  • Biotech & Medtech

Biotech & Medtech